Clinical trial · Interventional
Effect of Cardamom and Peppermint Oils on Chemotherapy-Related Nausea-Vomiting and Food Intake
Effect of Cardamom and Peppermint Oils on Chemotherapy-Related Nausea-Vomiting and Food Intake: Randomized Controlled Study
NCT07318779CI-TRIAL-00100150not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to evaluate the effect of inhaled cardamom oil on chemotherapy-related nausea, vomiting, and food intake and to compare these effects with those of inhaled peppermint oil.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cardomom oil | Other | — | UNRESOLVED |
| Peppermint Oil | Other | — | UNRESOLVED |
| sweet almond oil | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- peppermint oil
- description
- Thirty minutes before the chemotherapy session begins, one drop of essential oil will be applied to a piece of gauze. The gauze will then be attached to the patient's collar with a safety pin, positioned 20 cm away from the patient's nose. This procedure will be performed three times a day for five consecutive days.
- interventionNames
- Other: Peppermint Oil
- type
- ACTIVE_COMPARATOR
- label
- cardamom oil
- description
- Thirty minutes before the chemotherapy session begins, one drop of essential oil will be applied to a piece of gauze. The gauze will then be attached to the patient's collar with a safety pin, positioned 20 cm away from the patient's nose. This procedure will be performed three times a day for five consecutive days.
- interventionNames
- Other: cardomom oil
- type
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Volunteered to participate in the study, * Received at least one cycle and are continuing to receive either Adriamycin-cyclophosphamide or Adriamycin-cyclophosphamide-fluorouracil chemotherapy protocols, * Have an intact sense of smell. Exclusion Criteria: * Under 18 years of age, * Have neurocognitive impairment and are unable to answer the questionnaire, * Have a condition that may trigger nausea and vomiting, such as vertigo or motion sickness, * Have a chronic respiratory disease (with a history of asthma or other reactive airway diseases), * Have a known history of allergies, * Have a history of prolonged or excessive alcohol use, * Use any scented products during the intervention period, * Receive other complementary therapies for nausea and vomiting.
References
Publications (0)
Data not yet available
No reference posted for this study.